Invests in
Locations:
Min Investment:
$250,000.00Max Investment:
$15,000,000.00Target Investment:
$7,500,000.00
Skills
Education
- DU
Lists including Jacopo
Work Experience
2024
Chief Executive Officer
2024
2020
Advisor
2020
Agent Capital, a majority woman-owned international life sciences investment firm, support disruptive healthcare companies focused on novel, differentiated therapeutics and treatments that address unmet patient needs. Agent Capital aligns with scientists, entrepreneurs, and other investors to develop the next generation of healthcare innovations, leverages our industry expertise, and successful track record to source premier deals, accelerate value, and drive successful outcomes.
2022 - 2023
Chief Executive Officer
2022 - 2023
Pheast is a preclinical stage immuno-oncology company focused on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. Founded in 2020 as a spinout from Stanford University and led by scientific experts in innate immunity and cancer immunotherapy, Pheast is aiming to develop novel therapies for some of the most difficult-to-treat and aggressive cancers.
2022 - 2022
President, Global Commercial Operations
2022 - 2022
Leading US and International Commercial Organizations, Commercial Development, and Global Medical Affairs for Horizon Therapeutics
2016 - 2020
Chairman and CEO
2016 - 2020
2015 - 2016
Executive Vice President & President, Immunology
2015 - 2016
2014 - 2015
General Manager, US Hemophilia
2014 - 2015
2011 - 2012
Vice President, Sales & Marketing Baxter BioTherapeutics USA
2011 - 2012
2007 - 2009
Brand Leader
2007 - 2009
2005 - 2007
Director of Marketing
2005 - 2007